Skip to content

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02876744
Acronym
CORISMAP
Enrollment
101
Registered
2016-08-24
Start date
2017-04-04
Completion date
2020-12-15
Last updated
2021-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Brief summary

The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long term, a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy. The accuracy of the analysis of the vascularization of retinal layers of the posterior pole of the eye by the OCT-A , will detect, early and in a quantifiable manner, whether or not there are areas of macular ischemia in a patient. However, current technical limitations (small field analysis) of OCT-A imaging only allow a limited study of retina at the posterior pole of the fundus. This study seeks to demonstrate whether there is a link between macular ischemia detected by the OCT-A and peripheral retinal ischemia detected by the fluorescein angiographies, in diabetic patients.

Interventions

ophthalmologic examination including optical coherent tomography with angiography module

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diabetes type I or type II * follow-up with fluorescein angiography

Exclusion criteria

* known allergy to fluorescein * contra-indication to fluorescein angiography * pregnant or breast-feeding patient * technical impossibility to analyse retinal ischemic areas on fluorescein angiography or OCT-A.

Design outcomes

Primary

MeasureTime frame
Detection and measure of ischemic territories in central and peripheral retinaimmediate

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026